Frankfurt, Germany – 18 January 2025 – Nordberg Medical proudly introduces a new standard in facial anti-aging regeneration with the launch of JULÄINE™, its designed-for-purpose biostimulator. Designed and manufactured in Sweden, JULÄINE™ epitomises Scandinavian quality, innovation, and excellence in advanced aesthetic solutions.
A New Standard in Biostimulation
As a novel dermal bio-activating injectable, JULÄINE™ is at the forefront of regenerative beauty technology. Specifically designed to activate the skin’s natural ability to repair, rejuvenate, and regenerate collagen1, JULÄINE™ represents a fusion of innovative biocompatible2 science with the changing needs of today’s aesthetic patients who seek progressive, long-lasting, and natural-looking well-aging solutions that target skin health first3.
Harnessing the power of the innovative, proprietary LASYNPRO™ technology4 for Lactic-Acid induced synthesis of collagen protein, JULÄINE™’s unique microsphere design achieves superior dispersion and tissue integration1, with gradual release of Latic Acid for long-lasting regeneration1,5. Through a low-inflammatory signalling pathway1,6, JULÄINE™ activates fibroblasts to achieve collagen regeneration, achieving optimal tissue integration and healthy, non-fibrotic tissue development in the long term1.
JULÄINE™ offers a minimally invasive injectable solution that, unlike traditional filler treatments, is tailored to stimulate the body’s own regenerative processes7, providing natural and long-lasting results1,5,8.
“True Beauty Comes From Within”
“At Nordberg Medical, we believe in creating solutions that honour the body’s natural beauty while delivering exceptional results,” says Jack Yu, CEO and Founder of Nordberg Medical. “Our Biostimulator reflects our commitment to merging innovation with ethical, results-driven beauty practices. It is not just a product — it is a lifestyle upgrade for those who demand the very best.”
Who Is It For?
JULÄINE is designed for individuals seeking:
- Natural skin-tightening and rejuvenation without invasive procedures.
- Long-lasting results that enhance wrinkles and skin quality over time.
- A biocompatible and biodegradable solution to enhance their natural beauty.
Exclusive Launch Event
On 18 January 2025, JULÄINE™ debuted in Central Europe at an exclusive launch event in Munich, Germany on 18 January 2025. The event featured:
- Insights from leading dermatologists and plastic surgeons
- Results from ongoing clinical studies
- Live demonstrations highlighting the product’s unique benefits.
- Patient case studies that underscore the transformative power of this revolutionary biostimulator.
“We are thrilled not only to launch Nordberg Medical into the aesthetics space, but also to raise the bar for facial aesthetics overall,” says Amelia de Lange, Vice-President for Commercial Operations in Central Europe. “JULÄINE™ addresses an unmet need in the market with a solution that combines innovation and exceptional results.”
Availability
Following its launch, JULÄINE™ will be available exclusively in select clinics across Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg and Poland.
Join Us on This Journey
Discover the future of regenerative beauty with JULÄINE™ of Sweden. Learn more at www.julaineofsweden.com, and stay connected through our social media platforms for the latest updates:
Instagram: @nordbergmedical
Instagram: @nordbergmedical.de
Instagram: @julaineofsweden.de
For all medical enquiries, please contact Medinfo.DACH@nordbergmedical.com.
ABOUT NORDBERG MEDICAL
Nordberg Medical is a Swedish biotech pioneer, specialising in the development, production, and commercialisation of fully absorbable biomaterial-based medical devices, that replicate the principles of nature in anti-aging science.
Founded at the prestigious Karolinska Science Park, Nordberg Medical has transformed its humble beginnings by establishing a direct presence; and introducing their proprietary medical device, JULÄINE™ of Sweden, in various European and Asian markets, whilst continuing to obtain regulatory approvals in other geographies.
Nordberg Medical remains committed to expanding its manufacturing base to meet global demand while solidifying its position as a trailblazer in anti-aging innovation.
REFERENCES
- PLLA medical device animal implantation study. Data on file, 2020.
- JULÄINE™ biocompatibility reports. Data on file, 2024.
- BCG medical aesthetics provider surveys; DRG Clarivate; Market participant interviews; Company 10-Ks, BCG analysis.
- The effect of PLLA particles on usability, technical and clinical perspectives. Study performed by Research Institute of Sweden AB (RISE). Data on file, 2023.
- In vitro degradation testing report in comparison with PLLA-SCA. Data on file, 2020.
- Zhu & Dong, Poly-L-Lactic acid increases collagen gene expression and synthesis in cultured fibroblasts (HS68) through the TGF-β/Smad pathway. J. Cosmetic Dermatology, 2023;22:1213–1219.
- Capuana E, et al. Poly-L-Lactic Acid (PLLA)-Based Biomaterials for Regenerative Medicine: A Review on Processing and Applications. Polymers, 2022;14(6):1153.
- Multi-centre, Randomised and Parallel Controlled Clinical Trial of Polylactic Acid Facial Filler for Evaluation of Safety and Efficacy in Correcting Nasolabial Fold Wrinkles. Data on file, 2020.